Results 211 to 220 of about 539,919 (309)

Cracking the code of cancer immunotherapy resistance: emerging roles of pyroptosis and necroptosis. [PDF]

J Exp Clin Cancer Res
Lei K, Chen J, Deng Y, Peng Y, Zhai X, Ren X, Zhao J, Chen B, Jiang C.   +8 more
europepmc   +1 more source

Tailoring Advanced Metal‐Based Nanomedicines for Adaptable Nanodynamic Disease Therapies and Theranostics

Advanced Materials, EarlyView.
This review summarizes recent advances in metal‐based nanomaterials (MBNs) as multifunctional platforms for next‐generation diagnostics and nanodynamic therapies (NDTs), highlighting their structural tunability, diverse therapeutic modalities, and broad biomedical applications in oncology and infectious disease control.
Qihang Ding, Wenhao Li, Ling Mei, Suling Luo, Jing Tao, Chongxiu Shi, Hongping Yang, Wei Feng, Yungchang Chen, Yu Chen, Jong Seung Kim, Xue Shen   +11 more
wiley   +1 more source

Advances in Tumor Antigen Vaccines: A New Frontier in Cancer Immunotherapy. [PDF]

Int J Med Sci
Feng W, Zhao Y, Yu D, Jia W, Cao H, Zhang Y, Cao J, Li Z.   +7 more
europepmc   +1 more source

Neoantigen immunotherapy: a novel treatment for bladder cancer

Runxin Lv, Zhenzhu Liu, M. Lv, Yuze Song, Junlin Wang, Hui-Jun Mu, Yu Zhang, Xuejian Wang   +7 more
openalex   +1 more source

High‐Concentration Antibody Formulation via Solvent‐Based Dehydration

Advanced Materials, EarlyView.
Amorphous solid antibodies are encapsulated into hydrogel microparticles through a solvent‐based dehydration process. The solvent extracts water from antibody solution droplets, causing the antibody to concentrate, and precipitation of the antibody into amorphous solid is induced.
Talia Zheng, Lucas Attia, Janet Teng, Patrick S. Doyle   +3 more
wiley   +1 more source

Metallic nanomedicine in cancer immunotherapy. [PDF]

Acta Pharm Sin B
Li S, Wang X, Han H, Xiang S, Li M, Long G, Xia Y, Zhang Q, Li S.   +8 more
europepmc   +1 more source

Role of PD-1/PD-L1 signaling axis in oncogenesis and its targeting by bioactive natural compounds for cancer immunotherapy [PDF]

Yogesh Godiyal, Drishti Maheshwari, Hiroaki Taniguchi, Shweta S. Zinzuwadia, Yanelys Morera Díaz, Devesh Tewari, Anupam Bishayee   +6 more
openalex   +1 more source

Microneedles From Shape‐Preserving Crosslinked Poly(Vinyl Alcohol) Hydrogels: Minimising Interference in Transdermal Proteomics

Advanced Materials Technologies, EarlyView.
Hydrogel‐forming microneedle patches are developed using shape‐preserving PVA‐PVP hydrogels, with and without chitosan, for minimally invasive transdermal protein biomarker sampling. The optimised patches enable efficient interstitial fluid uptake and proteomic analysis, while minimising interference.
Achmad Himawan, Robert Graham, Fabiana Volpe‐Zanutto, Huanhuan Li, Anjali K. Pandya, Andi Nur Aisyah, Rina Agustina, Juan L. Paris, Juan Dominguez‐Robles, Lalitkumar K. Vora, Andi D. Permana, Christopher J. Scott, Ryan F. Donnelly   +12 more
wiley   +1 more source

Preclinical Characterization of SDFZ-8, a Highly Potent HDAC1 Inhibitor, for Cancer Immunotherapy. [PDF]

MedComm (2020)
Zhou Y, Du J, Li X, Zhao H, Xue J, Liu Y, Yang X, Yu J, Hou X, Fang H.   +9 more
europepmc   +1 more source

Multimodal Actuation and Environment Adaptive Strategies of Bio‐Inspired Micro/Nanorobots in Precision Medicine

Advanced Robotics Research, EarlyView.
An introduction for multidrive and environment‐adaptive micro/nanorobotics: design and fabrication strategies, intelligent actuation, and their applications. Various intelligent actuation approaches—magnetic, acoustic, optical, chemical, and biological—can be synergistically designed to enhance flexibility and adaptive behavior for precision medicine ...
Aiqing Ma, Han Gong, Jiacheng Ouyang, Liqi Chen, Tianfang Kang, Yiran He, Guojun Huang, Sidi Zheng, Ting Yin, Hong Pan, Lintao Cai   +10 more
wiley   +1 more source